Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6872
Source ID: NCT00349128
Associated Drug: Fenofibrate And Metformin Combination (Drug)
Title: Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Dyslipidemia/Glucose Metabolism Disorder
Interventions: DRUG: fenofibrate and metformin combination (drug)
Outcome Measures: Primary: Change in fasting triglycerides. | Secondary: Assessment of lipid and glucose metabolisms.
Sponsor/Collaborators: Sponsor: Solvay Pharmaceuticals
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2|PHASE3
Enrollment: 382
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2004-01
Completion Date:
Results First Posted:
Last Update Posted: 2007-09-03
Locations: Site 201, Katowice, Poland|Site 203, Katowice, Poland|Site 202, Warszawa, Poland|Site 204, Zabrze, Poland|Site 111, Dnipropetrovsk, Ukraine|Site 113, Dnipropetrovsk, Ukraine|Site 108, Kharkiv, Ukraine|Site 109, Kharkiv, Ukraine|Site 101, Kyiv, Ukraine|Site 102, Kyiv, Ukraine|Site 103, Kyiv, Ukraine|Site 104, Kyiv, Ukraine|Site 105, Kyiv, Ukraine|Site 106, Kyiv, Ukraine|Site 107, Kyiv, Ukraine|Site 112, Zaporizhya, Ukraine|Site 35, Acomb, United Kingdom|Site 21, Atherstone, United Kingdom|Site 14, Balsall Common, United Kingdom|Site 32, Bangor, United Kingdom|Site 23, Barry, United Kingdom|Site 36, Basingstoke, United Kingdom|Site 8, Bexhill-on-Sea, United Kingdom|Site 20, Camberley, United Kingdom|Site 22, Chesterfield, United Kingdom|Site 10, Chippenham, United Kingdom|Site 13, Coventry, United Kingdom|Site 31, Doncaster, United Kingdom|Site 15, Downpatrick, United Kingdom|Site 17, Ely, United Kingdom|Site 4, Ely, United Kingdom|Site 11, Fife, United Kingdom|Site 1, Frome, United Kingdom|Site 16, Harrow, United Kingdom|Site 5, Hastings, United Kingdom|Site 26, Haverfordwest, United Kingdom|Site 19, Keresley end, United Kingdom|Site 9, Kingswood, United Kingdom|Site 25, Newtownabbey, United Kingdom|Site 33, Northampton, United Kingdom|Site 28, Odiham, United Kingdom|Site 3, Paignton, United Kingdom|Site 12, Petersborough, United Kingdom|Site 7, Randalstown, United Kingdom|Site 27, Slough, United Kingdom|Site 6, Soham, United Kingdom|Site 2, South Glamorgan, United Kingdom|Site 34, Stratford on Avon, United Kingdom|Site 29, Swindon, United Kingdom|Site 30, Trowbridge, United Kingdom|Site 18, Yaxley, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00349128

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D311 Fenofibrate small molecule DB01039 Details
D089 Metformin small molecule DB00331 Details